Last Updated: 14 Sep 2024
Executive Summary
Agilent Technologies Inc (A) is a leading provider of analytical instrumentation and services to the life sciences, diagnostics, and applied chemical markets. The company has a strong financial position with a market capitalization of $39.45 billion, EBITDA of $1.56 billion, and EPS of $4.81. Agilent's stock is currently trading at $137.31, near its 50-day and 200-day moving averages. The company's fundamentals are solid, with strong revenue and earnings growth, and a healthy profit margin. Technically, the stock is in a bullish trend, with a positive MACD and RSI. Analysts are generally positive on the stock, with a consensus rating of "Hold."
Company Overview
Agilent Technologies Inc was founded in 1999 and is headquartered in Santa Clara, California. The company offers a wide range of products and services, including analytical instruments, consumables, software, and services. Agilent's products are used in a variety of applications, including drug discovery, environmental monitoring, and food safety. The company has a global presence, with operations in over 100 countries.
Fundamental Analysis
Agilent's financial performance has been strong in recent years. The company's revenue has grown at a CAGR of 5.5% over the past five years, and its EPS has grown at a CAGR of 10.5%. Agilent's profit margin is 21.7%, which is above the industry average. The company's balance sheet is also strong, with a debt-to-equity ratio of 0.4.
Technical Analysis
Agilent's stock is currently trading at $137.31, near its 50-day and 200-day moving averages. The stock is in a bullish trend, with a positive MACD and RSI. The stock's relative strength index (RSI) is 56, which indicates that the stock is not overbought or oversold.
Short Term Outlook
In the short term, Agilent's stock is likely to continue to trade in a range between $130 and $140. The stock's technical indicators are positive, but the market is currently volatile. If the market continues to sell off, Agilent's stock could fall below $130. However, if the market recovers, Agilent's stock could rise above $140.
Long Term Outlook
In the long term, Agilent's stock is likely to continue to perform well. The company's fundamentals are strong, and the demand for its products and services is expected to continue to grow. Agilent is also well-positioned to benefit from the growing trend towards personalized medicine.
Analyst Recommendations
Analysts are generally positive on Agilent's stock. The consensus rating on the stock is "Hold." Four analysts have a "Strong Buy" rating on the stock, three analysts have a "Buy" rating, 12 analysts have a "Hold" rating, one analyst has a "Sell" rating, and zero analysts have a "Strong Sell" rating. The average analyst target price on the stock is $146.04.
